Nourianz Tablet, Film Coated
Product Images NDC 42747-604

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nourianz (NDC 42747-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kyowa Kirin, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nourianz 01)

Chemical structure of istradefylline, the active ingredient in NOURIANZ. The diagram shows the molecular arrangement of atoms and bonds characteristic of this compound.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

NOURIANZ (istradefylline) tablets 20 mg per tablet. The packaging label displays the brand and generic names, strength, dosage form as film-coated tablets, and the quantity of 7 tablets in a blister card. The labeler is Kyowa Kirin, Inc. Additional information on storage temperature and a barcode are also visible.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

NOURIANZ (istradefylline) tablets 40 mg per tablet film-coated oral tablets packaging label. The box is marked as a professional sample not for sale and contains 7 tablets in a 7-count blister card. Manufactured by Kyowa Kirin, Inc., Bedminster, NJ. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.